Macnica (Macnica, headquartered at 1-6-3 Shin-Yokohama, Kohoku-ku, Yokohama, Japan; Representative Director and President: Kazumasa Hara, Capital: 11,194 million yen), a total service/solution provider in semiconductor, network, cybersecurity, and AI/IoT, announces that it has made an additional investment in Save (headquartered at 1-9-10 Nihonbashi Horidome-cho, Chuo-ku, Tokyo; Shoutarou Asano, President Board Director; hereinafter referred to as "Save Medical"), in which the company made a seed round investment in October 2018.

In recent years, expectations are rising for digital health as a new industry that will emerge from technological innovations in medical, health, and nursing care. Against the backdrop of the spread of communication infrastructure at the individual level, the development of health equipment and software products that apply digital technology such as ICT in the healthcare field is progressing, and investment in health tech ventures is increasing in the United States as well. is in

With this funding, Save Medical aims to obtain manufacturing and marketing approval for medical device apps for patients with lifestyle-related diseases and to start selling them. The medical device app aims to encourage behavioral changes and exert therapeutic effects through self-management support for patients with lifestyle-related diseases. It is attracting attention both at home and abroad. With this medical device app, Save Medical will provide new options for the treatment of lifestyle-related diseases and contribute to the development of medical care.

Going forward, we will continue to utilize Macnica 's world-leading technology knowledge and global network assets to support companies that develop equipment and software that apply digital technology in healthcare fields such as medicine, health, and nursing care. By doing so, we hope to contribute to innovation in the medical field.

* About Digital Therapeutics (DTx)
DTx is an evidence-based therapeutic intervention for patients using software intended to prevent, manage, or treat diseases. The software may be used alone or in combination with medicines, medical devices or other treatments.
In Japan, due to the enactment of the Pharmaceuticals and Medical Devices Law in 2014, programs (software) including mobile applications are now treated as standalone medical devices. The product you are looking for has not appeared.

*Company names and product names mentioned in the text are trademarks or registered trademarks of their respective companies.